Stock Taper 
BELLEVUE ASSET MANAGEMENT AG
Latest 13F filing data - Q4 2015
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Boston Scientific Corporation | BSX | 460K | $8.48M |
 Abbott Laboratories | ABT | 381.5K | $17.13M |
 Supernus Pharmaceuticals, Inc. | SUPN | 355K | $4.77M |
 Halozyme Therapeutics, Inc. | HALO | 318K | $5.51M |
 Inovio Pharmaceuticals, Inc. | INO | 265K | $1.78M |
 Coherus Oncology, Inc. | CHRS | 257K | $5.9M |
 Medtronic plc | MDT | 256.5K | $19.73M |
 Gilead Sciences, Inc. | GILD | 240.12K | $24.3M |
 Nektar Therapeutics | NKTR | 216K | $3.64M |
 Teva Pharmaceutical Industries Limited | TEVA | 176.72K | $11.6M |
 Community Health Systems, Inc. | CYH | 174.44K | $4.63M |
 Cardinal Health, Inc. | CAH | 171.48K | $15.31M |
 Exelixis, Inc. | EXEL | 170K | $959K |
 Stryker Corporation | SYK | 140.7K | $13.08M |
 Ionis Pharmaceuticals, Inc. | IONS | 138K | $8.55M |
 Arbutus Biopharma Corp | ABUS | 125K | $556K |
 Amgen Inc. | AMGN | 123K | $19.97M |
 UnitedHealth Group Incorporated | UNH | 120K | $14.12M |
 Pfizer Inc. | PFE | 110K | $3.55M |
 Baxter International Inc. | BAX | 110K | $4.2M |